Send me a link:

*Text messaging rates may apply.

 Dow Down 0.28% Nasdaq Down 0.17%

Hemispherx Biopharma, Inc. (HEB)

-NYSE MKT
0.26 0.00(1.50%) Jul 21, 4:00PM EDT
Prev Close:0.27
Open:0.27
Bid:0.25 x 100
Ask:0.30 x 100
1y Target Est:3.00
Beta:1.1
Next Earnings Date:N/A
Day's Range:0.26 - 0.27
52wk Range:0.19 - 0.55
Volume:731,675
Avg Vol (3m):957,762
Market Cap:48.17M
P/E (ttm):N/A
EPS (ttm):-0.10
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for HEB

Comparison

Symbol% ChgMkt Cap
HEBDown 1.50%48.17M
GILD136.46B
MRK169.50B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):265.79
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.11
Quarterly EPS Est (Mar-14) :N/A
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):-0.10

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Hemispherx Biopharma, Inc., a specialty pharmaceutical company, is engaged in the clinical development of new drug therapies based on natural immune system enhancing technologies for the treatment of viral and immune based chronic disorders in the... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback